Key points are not available for this paper at this time.
Limited data exists to evaluate the optimal management of outpatient beta blocker therapy when patients with heart failure with reduced ejection fraction (HFrEF) are admitted for acute decompensated heart failure (ADHF).
Bok et al. (Sun,) studied this question.